Cash flows from operating activities: | |
Net income (loss) | 37.39M |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Depreciation of property, plant and equipment | 117.69M |
Amortization of definite-lived intangible assets | 17.85M |
Amortization of convertible notes, debt discount and debt issuance costs | 16.4M |
Non-cash interest imputed on other long-term liabilities and related party financing obligation | |
Income tax benefit from restricted stock units released and common stock options exercised | |
Deferred income taxes | |
Stock-based compensation | 7.89M |
Impairment of long-lived assets | |
Realized gain on early payment of related party financing obligation | |
Net loss on sale of property, plant and equipment and other | |
Net unrealized loss on derivative assets and liabilities | |
Net realized foreign currency exchange loss | |
Changes in operating assets and liabilities, net of acquisition: | |
Accounts and notes receivable, net | 6.08M |
Inventories | -12.25M |
Prepaid expenses and other current assets | 3.13M |
Accounts payable | |
Accrued salaries, wages and benefits and other accrued expenses | -6.04M |
Net cash provided by operating activities | |
Cash flows from investing activities: | |
Purchase of property, plant and equipment and equipment deposits | -62.52M |
Proceeds from sale of property, plant and equipment and assets held for sale | |
Acquisition, net of cash acquired | 0 |
Restricted cash used for acquisition | |
Proceeds from the redemption of short-term investments | |
Net cash (used in) provided by investing activities | |
Cash flows from financing activities: | |
Proceeds from revolving loan | |
Repayment of long-term borrowings | -106.48M |
Proceeds from long-term borrowings | 0 |
Repayment of assumed long-term debt in acquisition | 0 |
Settlement of related party financing obligation | |
Proceeds from exercise of stock options | 123K |
Excess tax benefits from stock awards exercised or released | |
Net cash (used in) provided by financing activities | |
Effect of foreign currency exchange rates on cash and cash equivalents | -4.18M |
Net increase in cash and cash equivalents | 32.68M |
Cash and cash equivalents at beginning of period | 259.1M |
Cash and cash equivalents at end of period | 291.78M |
Supplemental disclosures of noncash investing and financing activities: | |
Accrued purchases of Equipment | 21.06M |
Issuance of Common stock and replacement award at fair value |